|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 9 May 2006
doi: 10.1242/jcs.02952
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
7 integrin

1 Department of Pharmacology, University of Nevada, Reno, NV 89557, USA
2 Department of Cell and Developmental Biology, University of Illinois, Urbana, IL 61801, USA
3 Nevada Transgenic Center, University of Nevada, Reno, NV 89557, USA
Author for correspondence (e-mail: dburkin{at}med.unr.edu)
Accepted 21 February 2006
The dystrophin glycoprotein complex links laminin in the extracellular matrix to the cell cytoskeleton. Loss of dystrophin causes Duchenne muscular dystrophy, the most common human X-chromosome-linked genetic disease. The
7ß1 integrin is a second transmembrane laminin receptor expressed in skeletal muscle. Mutations in the
7 integrin gene cause congenital myopathy in humans and mice. The
7ß1 integrin is increased in the skeletal muscle of Duchenne muscular dystrophy patients and mdx mice. This observation has led to the suggestion that dystrophin and
7ß1 integrin have complementary functional and structural roles. To test this hypothesis, we generated mice lacking both dystrophin and
7 integrin (mdx/
7-/-). The mdx/
7-/- mice developed early-onset muscular dystrophy and died at 2-4 weeks of age. Muscle fibers from mdx/
7-/- mice exhibited extensive loss of membrane integrity, increased centrally located nuclei and inflammatory cell infiltrate, greater necrosis and increased muscle degeneration compared to mdx or
7-integrin null animals. In addition, loss of dystrophin and/or
7 integrin resulted in altered expression of laminin-
2 chain. These results point to complementary roles for dystrophin and
7ß1 integrin in maintaining the functional integrity of skeletal muscle.
Key words:
7 integrin, Dystrophin, Transgenic mice, Double knockout, Skeletal muscle, Muscular dystrophy
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
F. J. Conti, S. J. Monkley, M. R. Wood, D. R. Critchley, and U. Muller Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions Development, November 1, 2009; 136(21): 3597 - 3606. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Welser, J. E. Rooney, N. C. Cohen, P. B. Gurpur, C. A. Singer, R. A. Evans, B. A. Haines, and D. J. Burkin Myotendinous Junction Defects and Reduced Force Transmission in Mice that Lack {alpha}7 Integrin and Utrophin Am. J. Pathol., October 1, 2009; 175(4): 1545 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Rooney, P. B. Gurpur, and D. J. Burkin Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy PNAS, May 12, 2009; 106(19): 7991 - 7996. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, C. Long, Y. Yue, and D. Duan Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice Hum. Mol. Genet., April 1, 2009; 18(7): 1209 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Peter, C. Y. Ko, M. H. Kim, N. Hsu, N. Ouchi, S. Rhie, Y. Izumiya, L. Zeng, K. Walsh, and R. H. Crosbie Myogenic Akt signaling upregulates the utrophin-glycoprotein complex and promotes sarcolemma stability in muscular dystrophy Hum. Mol. Genet., January 15, 2009; 18(2): 318 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Rooney, P. B. Gurpur, Z. Yablonka-Reuveni, and D. J. Burkin Laminin-111 Restores Regenerative Capacity in a Mouse Model for {alpha}7 Integrin Congenital Myopathy Am. J. Pathol., January 1, 2009; 174(1): 256 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Conti, A. Felder, S. Monkley, M. Schwander, M. R. Wood, R. Lieber, D. Critchley, and U. Muller Progressive myopathy and defects in the maintenance of myotendinous junctions in mice that lack talin 1 in skeletal muscle Development, June 1, 2008; 135(11): 2043 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Elsherif, M. S. Huang, S.-Y. Shai, Y. Yang, R. Y. Li, J. Chun, M. A. Mekany, A. L. Chu, S. J. Kaufman, and R. S. Ross Combined Deficiency of Dystrophin and {beta}1 Integrin in the Cardiac Myocyte Causes Myocardial Dysfunction, Fibrosis and Calcification Circ. Res., May 9, 2008; 102(9): 1109 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-V. Wang, L.-W. Chang, K. Brixius, S. A. Wickstrom, E. Montanez, I. Thievessen, M. Schwander, U. Muller, W. Bloch, U. Mayer, et al. Integrin-linked kinase stabilizes myotendinous junctions and protects muscle from stress-induced damage J. Cell Biol., March 5, 2008; 180(5): 1037 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, D. J. Burkin, and S. J. Kaufman Increasing {alpha}7{beta}1-integrin promotes muscle cell proliferation, adhesion, and resistance to apoptosis without changing gene expression Am J Physiol Cell Physiol, February 1, 2008; 294(2): C627 - C640. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sharma, T. Tran, G. L. Stelmack, K. McNeill, R. Gosens, M. M. Mutawe, H. Unruh, W. T. Gerthoffer, and A. J. Halayko Expression of the dystrophin-glycoprotein complex is a marker for human airway smooth muscle phenotype maturation Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L57 - L68. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Gheyara, A. Vallejo-Illarramendi, K. Zang, L. Mei, R. St.-Arnaud, S. Dedhar, and L. F. Reichardt Deletion of Integrin-Linked Kinase from Skeletal Muscles of Mice Resembles Muscular Dystrophy Due to {alpha}7 1-Integrin Deficiency Am. J. Pathol., December 1, 2007; 171(6): 1966 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Welser, N. Lange, C. A. Singer, M. Elorza, P. Scowen, K. D. Keef, W. T. Gerthoffer, and D. J. Burkin Loss of the {alpha}7 Integrin Promotes Extracellular Signal-Regulated Kinase Activation and Altered Vascular Remodeling Circ. Res., September 28, 2007; 101(7): 672 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Milner and S. J. Kaufman {alpha}7{beta}1 Integrin Does Not Alleviate Disease in a Mouse Model of Limb Girdle Muscular Dystrophy Type 2F Am. J. Pathol., February 1, 2007; 170(2): 609 - 619. [Abstract] [Full Text] [PDF] |
||||